189 related articles for article (PubMed ID: 22584707)
1. RET haplotype, not linked to the C620R activating mutation, associated with Hirschsprung disease in a novel MEN2 family.
Quedas EP; Longuini VC; Sekiya T; Coutinho FL; Toledo SP; Tannuri U; Toledo RA
Clinics (Sao Paulo); 2012; 67 Suppl 1(Suppl 1):57-61. PubMed ID: 22584707
[TBL] [Abstract][Full Text] [Related]
2. Mutations of the RET proto-oncogene in the multiple endocrine neoplasia type 2 syndromes, related sporadic tumours, and hirschsprung disease.
Eng C; Mulligan LM
Hum Mutat; 1997; 9(2):97-109. PubMed ID: 9067749
[TBL] [Abstract][Full Text] [Related]
3. Occurrence of the Cys611Tyr mutation and a novel Arg886Trp substitution in the RET proto-oncogene in multiple endocrine neoplasia type 2 families and sporadic medullary thyroid carcinoma cases originating from the central region of Portugal.
Prazeres HJ; Rodrigues F; Figueiredo P; Naidenov P; Soares P; Bugalho MJ; Lacerda M; Campos B; Martins TC
Clin Endocrinol (Oxf); 2006 Jun; 64(6):659-66. PubMed ID: 16712668
[TBL] [Abstract][Full Text] [Related]
4. Multiple endocrine neoplasia syndromes, children, Hirschsprung's disease and RET.
Moore SW; Zaahl MG
Pediatr Surg Int; 2008 May; 24(5):521-30. PubMed ID: 18365214
[TBL] [Abstract][Full Text] [Related]
5. Molecular mechanisms of RET receptor-mediated oncogenesis in multiple endocrine neoplasia 2.
Wagner SM; Zhu S; Nicolescu AC; Mulligan LM
Clinics (Sao Paulo); 2012; 67 Suppl 1(Suppl 1):77-84. PubMed ID: 22584710
[TBL] [Abstract][Full Text] [Related]
6. RET codon 609 mutations: a contribution for better clinical managing.
Mian C; Sartorato P; Barollo S; Zane M; Opocher G
Clinics (Sao Paulo); 2012; 67 Suppl 1(Suppl 1):33-6. PubMed ID: 22584703
[TBL] [Abstract][Full Text] [Related]
7. Screening of RET gene mutations in Chinese patients with medullary thyroid carcinoma and their relatives.
Wang J; Zhang B; Liu W; Zhang Y; Di X; Yang Y; Yan D
Fam Cancer; 2016 Jan; 15(1):99-104. PubMed ID: 26254625
[TBL] [Abstract][Full Text] [Related]
8. RET proto-oncogene testing in infants presenting with Hirschsprung disease identifies 2 new multiple endocrine neoplasia 2A kindreds.
Fialkowski EA; DeBenedetti MK; Moley JF; Bachrach B
J Pediatr Surg; 2008 Jan; 43(1):188-90. PubMed ID: 18206480
[TBL] [Abstract][Full Text] [Related]
9. [From gene to disease; from the RET gene to multiple endocrine neoplasia types 2A and 2B, sporadic and familial medullary thyroid carcinoma, Hirschsprung disease and papillary thyroid carcinoma].
Hofstra RM; van der Luijt RB; Lips CJ
Ned Tijdschr Geneeskd; 2001 Nov; 145(46):2217-21. PubMed ID: 11757244
[TBL] [Abstract][Full Text] [Related]
10. Familial associations in medullary thyroid carcinoma with Hirschsprung disease: the role of the RET-C620 "Janus" genetic variation.
Moore SW; Zaahl M
J Pediatr Surg; 2010 Feb; 45(2):393-6. PubMed ID: 20152359
[TBL] [Abstract][Full Text] [Related]
11. A novel Czech kindred with familial medullary thyroid carcinoma and Hirschsprung's disease.
Dvoráková S; Dvoráková K; Malíková M; Skába R; Vlcek P; Bendlová B
J Pediatr Surg; 2005 Jun; 40(6):e1-6. PubMed ID: 15991157
[TBL] [Abstract][Full Text] [Related]
12. The Hirschsprung's-multiple endocrine neoplasia connection.
Moore SW; Zaahl M
Clinics (Sao Paulo); 2012; 67 Suppl 1(Suppl 1):63-7. PubMed ID: 22584708
[TBL] [Abstract][Full Text] [Related]
13. Impact of RET proto-oncogene analysis on the clinical management of multiple endocrine neoplasia type 2.
Toledo SP; dos Santos MA; Toledo Rde A; Lourenço DM
Clinics (Sao Paulo); 2006 Feb; 61(1):59-70. PubMed ID: 16532227
[TBL] [Abstract][Full Text] [Related]
14. RET mutation Tyr791Phe: the genetic cause of different diseases derived from neural crest.
Vaclavikova E; Dvorakova S; Sykorova V; Bilek R; Dvorakova K; Vlcek P; Skaba R; Zelinka T; Bendlova B
Endocrine; 2009 Dec; 36(3):419-24. PubMed ID: 19826964
[TBL] [Abstract][Full Text] [Related]
15. Clinical utility of genetic diagnosis for sporadic and hereditary medullary thyroid carcinoma.
Elisei R; Bottici V; Cappagli V; Ramone T; Tacito A; Ciampi R; Romei C
Ann Endocrinol (Paris); 2019 Jun; 80(3):187-190. PubMed ID: 31053251
[TBL] [Abstract][Full Text] [Related]
16. Mutational analysis of the RET proto-oncogene in 71 Japanese patients with medullary thyroid carcinoma.
Shirahama S; Ogura K; Takami H; Ito K; Tohsen T; Miyauchi A; Nakamura Y
J Hum Genet; 1998; 43(2):101-6. PubMed ID: 9621513
[TBL] [Abstract][Full Text] [Related]
17. A founding locus within the RET proto-oncogene may account for a large proportion of apparently sporadic Hirschsprung disease and a subset of cases of sporadic medullary thyroid carcinoma.
Borrego S; Wright FA; Fernández RM; Williams N; López-Alonso M; Davuluri R; Antiñolo G; Eng C
Am J Hum Genet; 2003 Jan; 72(1):88-100. PubMed ID: 12474140
[TBL] [Abstract][Full Text] [Related]
18. Biological properties of Ret with cysteine mutations correlate with multiple endocrine neoplasia type 2A, familial medullary thyroid carcinoma, and Hirschsprung's disease phenotype.
Ito S; Iwashita T; Asai N; Murakami H; Iwata Y; Sobue G; Takahashi M
Cancer Res; 1997 Jul; 57(14):2870-2. PubMed ID: 9230192
[TBL] [Abstract][Full Text] [Related]
19. Management of patients with hereditary medullary thyroid carcinoma.
Fitze G
Eur J Pediatr Surg; 2004 Dec; 14(6):375-83. PubMed ID: 15630638
[TBL] [Abstract][Full Text] [Related]
20. Germline RET mutation carriers in Japanese patients with apparently sporadic medullary thyroid carcinoma: A single institution experience.
Kihara M; Miyauchi A; Yoshioka K; Oda H; Nakayama A; Sasai H; Yabuta T; Masuoka H; Higashiyama T; Fukushima M; Ito Y; Kobayashi K; Miya A
Auris Nasus Larynx; 2016 Oct; 43(5):551-5. PubMed ID: 26837867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
